FDA’s Office Of Regulatory Affairs Scrutinizes Recalls Process
This article was originally published in The Gray Sheet
Improving the efficiency of the recall process is one of ORA’s priorities for fiscal 2012. And CDRH says its own recall improvements efforts are starting to bear fruit.
You may also be interested in...
Legislation introduced Dec. 15 would give FDA PMA-like authorities over 510(k) devices, including the power to require post-clearance studies. Industry says the bill is unnecessary.
The Government Accountability Office is urging FDA to clarify and strengthen its oversight of medical device recalls.
FDA's device center has formed a new team to improve the way medical device recalls are carried out and communicated to the public.